The pulmonary immune system consists of a network of tissue-resident cells as well as immune 4 cells that are recruited to the lungs during infection and/or inflammation. How the two immune 5 components cross-talk during an acute viral infection is not well understood. Intranasal infection 6 of mice with vaccinia virus causes lethal pneumonia and systemic dissemination. Here we report 7 that vaccinia host range protein C7 is a critical virulence factor. Vaccinia virus with deletion of C7 8 (VACV∆C7L) is non-pathogenic in wild-type C57BL/6J mice, but it gains virulence in mice 9 lacking STAT2, or IFNAR1, or MDA5/STING. We provide evidence that lung type II alveolar 10 epithelial cells (AECs) provide first-line of defense against VACV∆C7L infection by inducing 11 IFN-b and IFN-stimulated genes via the activation of the MDA5 and STING-mediated nucleic 12 acid-sensing pathways. This leads to recruitment of CCR2 + inflammatory monocytes into the lungs 13 to fight against viral dissemination. 14
INTRODUCTION 15 16
Poxviruses are large cytoplasmic DNA viruses that are important human and veterinary pathogens. 17 Smallpox, a highly contagious infectious disease with a high mortality rate that had claimed 18 hundreds of millions of lives throughout the history, is caused by a human specific poxvirus--19 variola virus--through inhalation of airborne droplets. Prior to Edward Jenner's vaccination using 20 skin scarification with cowpox, variolation by inhalation of dried smallpox scabs was practiced in 21
China as early as in the 10 th century to induce immunity against smallpox. Later, vaccinia virus 22 became the vaccine strain of choice against smallpox and was used successfully throughout the 23 world, which lead to smallpox eradication in 1980. 24
25
Studies on intranasal infection with vaccinia virus using mice may shed light on how the lung 26 immune system defends against poxvirus infection. Extensive studies have been conducted to 27 evaluate the pathogenicity of the virus and to define its virulence factors. By using genetic 28 knockout mice or cell type depletion antibodies, several immune cell types and factors have been 29 -/-mice are more susceptible to VACV infection with more 32 weight loss after infection, supporting a role of CD103 + /CD8a + DCs in cross-priming CD8 + T 33 cells (Desai et al., 2018) . In addition, cGAS -/-mice are more susceptible to VACV infection, which 34 suggests that cGAS-dependent DNA sensing is important for host defense against a DNA virus 35 (Schoggins et al., 2014) . All of these studies were performed using a low dose of wild type (WT) 36 VACV infection because of the virulence nature of this virus. provides us with a model to evaluate the lung innate immune responses to acute pulmonary 49 infection with a DNA virus. We found that VACV∆C7L infection triggers the release of IFN-b, 50 CCL2, CXCL9, and CXCL10 into bronchioalveolar (BAL), whereas WT VACV infection fails to 51 do so. Infection of primary lung AECII with VACV∆C7L in vitro leads to the induction of IFNB 52 and IFN-stimulated genes (ISGs), which is dependent on the MDA5-dependent cytosolic dsRNA-53 sensing pathway as well as the STING-dependent cytosolic DNA-sensing pathway. 54
55
Given that both IFNAR1 and STAT2-deficient mice are more susceptible to VACV∆C7L 56 infection, we hypothesize that type I IFN signaling plays an important role in restricting 57 VACV∆C7L, either through stimulating IFNAR on the lung AEC and/or hematopoietic cell 58
populations. To probe the relative contributions of lung non-hematopoietic resident cells versus 59
hematopoietic cells in host defense against VACV∆C7L, we generated bone marrow chimeric 60 mice. Our results indicate that the IFNAR signaling on the non-hematopoietic cells (likely the 61 AECII) plays a critical role in host defense, and IFNAR signaling on hematopoietic cells also 62 contributes. Using IFNAR1 fl/fl -Sftpc cre-ERT2 mice, we showed that type I IFN signaling on lung 63
AECIIs is important for host defense against VACV∆C7L infection. 64
65
To probe whether myeloid cells play a role in host defense against VACV∆C7L infection, we 66 transiently depleted CCR2 + inflammatory monocytes in CCR2-DTR mice through administration 67 of diphtheria toxin (DT), and found that depletion of CCR2 + inflammatory monocytes renders the 68 mice susceptible to VACV∆C7L infection. Using CCR2-GFP mice, we found that after 69 factor, we generated a mutant vaccinia (Western Reserve) strain lacking the C7L gene through 84 homologous recombination. The recombinant virus VACV∆C7L, which expresses mCherry under 85 the vaccinia synthetic early/late promoter, is replication-competent in BSC40 cells (data not 86 shown). We performed intranasal infection of WT VACV or VACV∆C7L in 6-8 week old WT 87 C57BL/6J mice. WT VACV infection at 2 x 10 6 pfu per mouse caused rapid weight loss and 100% 88 lethality ( Figures 1A and 1B) . WT VACV infection at 2 x 10 5 pfu per mouse resulted in an average 89 of 22% weight loss, and 40% mortality ( Figures 1A and 1B) . By contrast, VACV∆C7L infection 90 at the highest dose (2 x 10 7 PFU) results in less than 20% weight loss, and all of the mice recovered 91 their weight at 11 to 12 days post infection ( Figures 1C and 1D ). These results demonstrate that 92 VACV∆C7L is attenuated by at least 100-fold compared with WT VACV in an intranasal infection 93 model, and therefore C7 is a virulence factor. 94
95
Type I IFN signaling is crucial for host control of VACV∆C7L infection in the lungs. To probe 96 the mechanism of attenuation, we first tested whether type I IFN signaling is important for host 97 defense against VACV∆C7L. We intranasally infected WT, STAT2 -/-, or IFNAR1 -/-mice with 98 VACV∆C7L at a dose of 2 x 10 7 pfu and monitored weight loss and survival of the mice over time. 99
We found that in contrast to WT mice, the STAT2 -/-and IFNAR -/-mice were highly susceptible to 100 VACV∆C7L infection, with rapid weight loss, severe illness, and death ( Figures 1E and 1F) . The 101 median survival times for STAT2 -/-and IFNAR1 -/-mice were 7 days and 8 days, respectively 102 ( Figure 1F) . We compared the viral titers in various tissues from WT, STAT2 -/-, or IFNAR1
-/-103 mice at day 4 post infection with VACV∆C7L at 2 x 10 7 pfu. We found that VACV∆C7L infection 104 of WT mice caused localized infection in the lungs without dissemination of the virus or viremia 105 ( Figure 1I ). VACV∆C7L infection caused higher viral titers in the lungs of STAT2 -/-or IFNAR1 -
106
/-mice compared with those in the WT mice ( Figure 1I ). We also observed viremia and 107 dissemination of the virus to various distant organs including livers, spleens, and brains in STAT2 (Figures 2A and 2B) . 143
Luminex analysis of proinflammatory cytokines and chemokines in the BAL showed that 144 VACV∆C7L infection resulted in the release of IL-6, Ccl2, IFN-g, CXCL10, CXCL9 into the 145 BAL, whereas both WT VACV and VACV∆C7L induced VEGF release (Figures 2A and 2B) . These results indicate that overexpression of C7 in HEK293T cells exerts an inhibitory effect on 218 STING, MAVS, TLR3/poly (I:C), TRIF, and TBK1-induced IFNB promoter activity. IRF3 is a 219 member of the interferon regulatory transcription factor (IRF) family and it is an essential 220 transcription factor for the IFNB promoter. Since TBK1/IRF3 is a common node in these diverse 221 DNA-and RNA-sensing pathways, it is possible that C7 targets the step that leads to the activation 222 of IRF3, resulting in the failure of IRF3 phosphorylation. We found that over-expression of C7 223 caused a 70% reduction of IRF3-induced IFNB promoter activity ( Figure 3F ), whereas 224 overexpression of C7 failed to reduce IRF3-5D-induced IFNB promoter activity ( Figure 3G) . 225 IRF3-5D is a constitutive active, phosphorylation-mimetic mutation of IRF3. In addition, we found 226 that C7 does not affect NFKB gene activation induced by TRIF overexpression (Figure 3H) . 227
Taken together, our results indicate that C7 functions through inhibition of IRF3 activation. 228 229
Overexpression of vaccinia C7 in immune cells inhibits IFNB gene induction and IFN-b 230
signaling. To assess the effect of vaccinia C7 in IFNB gene induction in immune cells, we 231 generated two cell lines stably expressing vaccinia C7, including murine macrophage RAW264.7 232 and human THP-1. An empty vector with a drug selection marker was also used to generate a 233 control cell line. THP-1 stable cell line expressing C7 or with an empty vector were differentiated 234 by phorbol-12-myristate-13-acetate (PMA) for 3 days before they were used for the experiments. showed the desired reconstitution of hematopoietic cells in the blood (Figure S3A-S3D) . 283 contributing factor for its virulence, we should be able to rescue mice from lethal infection with 311 WT VACV. To test that, we infected 6-8 week old WT C57BL/6J mice with WT VACV at 2 x 312 10 5 pfu or 2 x 10 6 pfu. They were either treated with intranasal administarion of IFN-b (1 µg per 313 mouse) or PBS. We monitored weight and survival over time ( Figure S4A) . We found that IFN-314 b treatment started one day after WT VACV infection at 2 x 10 5 pfu or 2 x 10 6 pfu successfully 315 slowed down weight loss and protected mice from lethality ( Figure S4B-S4E 
5E-5G). We assessed viral-specific CD8 + T cells responses by stimulating them with vaccinia 338
dominant B8 epitope TSYKFESV and performing intracellular IFN-g cytokine staining. 339 SIINFEKL peptide, an irrelevant epitope from chicken ovalbumin, was used as a negative control. 340
We found that VACV∆C7L infection resulted in the extravasation of viral-specific CD8 + T cells 341 into the BAL (Figures 5H-5I (Figures 5J and 5L) . We also found that VACV∆C7L 351 infection resulted in higher percentages of vaccinia B8-specific CD8 + T cells in lungs compared 352 with WT VACV (Figures 5K and 5M) . These results suggest that host innate immunity, including 353 (Figures 6A-6B) . 360
Antibody depletion of NK cells did not affect VACV∆C7L-induced weight loss and did not 361
enhance mortality (Figures 6C-6D) . Furthermore, intranasal application of liposomal clodronate 362 resulted in depletion of alveolar macrophages, However, this treatment did not exacerbate 363
VACV∆C7L-induced weight loss. These results indicate that T, B, NK, and alveolar macrophages 364
are not important for controlling VACV∆C7L pulmonary infection in this intranasal infection 365
model. 366 367

CCR2
+ inflammatory monocytes contribute to host restriction of VACV∆C7L infection in 368 the lungs. Our immune cell profiling of BAL showed that Ly6C + CD11b + inflammatory monocytes 369 are the major myeloid cell population extravasated into the BAL at day 3 and 6 post VACV∆C7L 370 infection (Figures 5B and S3B) . To examine the function of CCR2 + Ly6C hi inflammatory 371 monocytes in host defense against VACV∆C7L infection, we used CCR2-DTR mice to transiently 372 deplete CCR2 + monocytes prior to VACV∆C7L infection by administering diphtheria toxin (DT) 373 intraperitoneally (Hohl et al., 2009 ). We found that CCR2-DTR mice treated with DT were much 374 more susceptible to VACV∆C7L infection compared with WT mice treated with DT, with more 375 rapid weight loss and 100% mortality at day 7 or 8 post infection (Figures 6E-6F The MDA5
-/-STING Gt/Gt mice are highly susceptible to VACV∆C7L infection ( Figures 1G, 1H  396 
and 1J). The lung AECIIs from MDA5
-/-STING Gt/Gt mice fail to induce the expression of IFNB 397 and inflammatory cytokine and chemokine genes upon VACV∆C7L infection ( Figures 2H and  398 
2I). We hypothesized that the lack of induction of innate immunity in the lung epithelium of 399
MDA5
-/-STING Gt/Gt mice would result in the failure of recruiting CCR2 + monocytes. To test that, 400
we performed intranasal infection of VACV∆C7L in WT and MDA5 -/-STING Gt/Gt mice. PBS was 401 used as a mock infection control in WT mice. Lungs were collected at day 3 post infection and 402 we analyzed myeloid cell populations. We found that intranasal infection of VACV∆C7L 403 resulted in the recruitment of Ly6C + inflammatory monocytes, and the generation of Lyve1 + and 404
Lyve1
-IMs in WT mice (Figures 7B-7D) . However, VACV∆C7L induced monocytes and 405
-IMs were markedly reduced in MDA5 -/-STING Gt/Gt mice (Figures 7B-7D ). This indicates 406 and Bowie, 2014; Seet et al., 2003) . In this study, we focused on the host-range protein C7 and its 430 inhibitory effect on IFN production. Vaccinia C7 was discovered as a host range protein that allows 431 vaccinia replication in human cells (Perkus et al., 1990) . It is functionally equivalent to another 432 vaccinia host range protein K1 and therefore deletion of both C7L and K1L gene from the vaccinia 433 genome renders the virus replication-incompetent in certain human cells (Perkus et al., 1990) . One 434 of the myxoma homologs of C7 encoded by the M62R has been shown to interact with host factor 435 SAMD9 protein in human cells (Liu et al., 2011) . Through an unbiased genome-wide siRNA 436 screen in human cells, SAMD9 and WDR6 were identified as host restriction factors for vaccinia 437 virus lacking both the C7L and K1L genes (Sivan et al., 2015) . C7 can also bind to SAMD9L in 438 mouse, and VACV with both C7L and K1L deletion is highly attenuated in an intranasal infection 439 Monocytes egress from the bone marrow to the blood circulation in response to infection and 527 they also migrate to the infected or inflamed tissue in a CCR2-dependent manner where they 528 further differentiate into other cell types, including inflammatory DCs and macrophages. CCR2 5-10 WT mice in each group were anesthetized and infected intranasally with increasing doses of 600 WT VACV or VACV∆C7L at indicated pfu, inoculated to both nostrils in 20 µl each. Mice were 601 monitored and weight daily. Mice that had lost over 30% of initial weight were be euthanized. 602
Kaplan-Meier survival curves were determined. 603
604
Cytokine production assays 605
For in vivo experiments, 1 ml of bronchoalveolar lavage was used for cytokine measurements. For 606 in vitro experiments, cell supernatant was collected for analysis. Most cytokines were measured 607 using commercial mouse ELISA kits. IFN-β was measured by ELISA (PDL) and CCL4 and CCL5 608
were measured by ELISA (R&D). The Luminex assay was performed using the Cytokine Mouse 609 permeabilized with 0.5% Triton X-100 in PBS for 5 min. Then blocked in 5% goat serum (Sigma), 631 3% bovine serum albumin (Fisher) and 0.1% Triton X-100 for 1 hr at room temperature. Primary 632 antibodies were incubated overnight at 4°C at the indicated dilutions: chicken anti-GFP (1:1000, 633
Abcam), rabbit anti-SP-C (1:1000, Millipore). Alexa Fluor-coupled secondary antibodies (1:1000, 634 Invitrogen) were incubated at room temperature for 60 min. After antibody staining, sections were 635 embedded in ProLong Gold Antifade Mountant (ThermoFisher). Images were acquired using a 636 confocal microscope (Leica TCS SP8). All the images were further processed with Image J 637
software. 638 639
Tamoxifen and Diphtheria Toxin Administration 640
Diphtheria toxin was obtained from Sigma, reconstituted at 1 mg/ml in PBS, and frozen at −80°C. 641
Mice received 10 ng/g DT via the i.p. route in 0.2-0.3 ml PBS. Tamoxifen (Sigma) was a 40 mg/ml 642 stock solution in corn oil (Sigma) and given 4 mg via intraperitoneal (IP) injection x 4-5 doses. 
